Corneal Collagen Crosslinking and Vision-Related Quality of Life: Outcomes in Keratoconus Patients
DOI:
https://doi.org/10.48560/rspo.38322Keywords:
Keratoconus, Quality of life, Corneal Cross-Linking, Surveys and QuestionnairesAbstract
INTRODUCTION: Keratoconus (KC) is a progressive corneal ectatic disorder that significantly impacts patients’ quality of life. This study aims to evaluate the effect of corneal collagen crosslinking (CXL) on vision-related quality of life in keratoconus patients using the Portuguese version of the Keratoconus Outcomes Research Questionnaire (KORQ).
METHODS: Prospective observational study including patients with progressive KC who underwent CXL, as well as a group of stable KC patients without indications for treatment. Patients undergoing CXL completed the KORQ before treatment and six months after. Patients not receiving any treatment also answered the questionnaire at the same time points. A comparison between the KORQ scores of both groups was performed. Relations between KORQ scores and best-corrected visual acuity (BCVA), keratometric and refractive parameters were also assessed.
RESULTS: In the CXL group, the Activity Limitation (AL) subscale improved from 50.86 preoperatively to 52.09 (p=0.746) six months after treatment, while the Symptoms subscale showed a greater increase from 46.86 to 54.80 (p=0.080). The BCVA significantly improved from 0.327 to 0.157 logMAR (p<0.05). Significant reductions (p<0.05) were also observed in maximum keratometry (Kmax), flattest keratometry (K1), and steepest keratometry (K2). In contrast, untreated patients exhibited minimal changes in both visual parameters and KORQ scores. A significant interaction (p=0.036) was observed between time and treatment in the Symptoms subscale, indicating that the CXL group experienced a greater improvement in symptom perception over time.
CONCLUSION: This study underscores the effectiveness of CXL in treating keratoconus by stabilizing the disease and seeming to improve symptom perception. Using patient-reported outcome measures like KORQ is crucial for accurately assessing the impact of the disease and its treatments on patients’ quality of life.
Downloads
References
Santodomingo-Rubido J, Carracedo G, Suzaki A, Villa-Collar C, Vincent S, Wolfsohn J. Keratoconus: An updated review. Contact Lens and Anterior Eye. 2022;45:101559. doi:10.1016/j.clae.2021.101559.
Hashemi H, Heydarian S, Hooshmand E, Saatchi M, Yekta A, Aghamirsalam M, et al. The Prevalence and Risk Factors for Keratoconus: A Systematic Review and Meta-Analysis. Cornea. 2020;39:263. doi:10.1097/ICO.000000000002150.
Ferrini E, Aleo D, Posarelli C, Figus M, Miccoli M, Gabbiellini G. Impact of corneal collagen cross-linking on vision-related quality of life measured with the keratoconus outcomes research questionnaire (KORQ) in patients with keratoconus. Contact Lens and Anterior Eye. 2023;46:101746.. doi:10.1016/j.clae.2022.101746.
Kurna S, Altun A, Gencaga T, Akkaya S, Sengor T. Vision Related Quality of Life in Patients with Keratoconus. 2014;2014:694542. doi:10.1155/2014/694542.
Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-7. doi:10.1016/S0002-9394(02)02220-1.
Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat L. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term results. J Cataract Refract Surg. 2008;34:796-801. doi:10.1016/j.JCRS.2007.12.039
Chan C, Sharma M, Wachler B. Effect of inferior-segment Intacs with and without C3-R on keratoconus. J Cataract Refract Surg. 2007;33:75-80. doi:10.1016/j.JCRS.2006.09.012.
Pinto R, Abe R, Gomes F, Barbisan P, Martini A, Borges D, et al. Quality of life in keratoconus: evaluation with Keratoconus Outcomes Research Questionnaire (KORQ). Sci Rep. 2021;11:12970. doi:10.1038/s41598-021-92346-1
Kymes S, Walline J, Zadnik K, Gordon M, Collaborative Longitudinal Evaluation of Keratoconus study group. Quality of life in keratoconus. Am J Ophthalmol. 2004;138:527-35. doi:10.1016/j.ajo.2004.04.031.
Kymes S, Walline J, Zadnik K, Sterling J, Gordon O, Collaborative Longitudinal Evaluation of Keratoconus study group. Changes in the Quality of Life of People with Keratoconus. Am J Ophthalmol. 2008;145:611. doi:10.1016/j.AJO.2007.11.017
Ortiz-Toquero S, Perez S, Rodriguez G, De Juan V, Mayo-Iscar A, Martin R. The influence of the refractive correction on the vision-related quality of life in keratoconus patients. Qual Life Res. 2016;25:1043-51. doi:10.1007/s11136-015-1117-1.
Khadka J, Schoneveld P, Pesudovs K. Development of a keratoconus-specific questionnaire using rasch analysis. Optom Vis Sci. 2017;94:395-403. doi:10.1097/OPX.000000000001035.
Pinto R, Gomes F, Arieta C, Alves M. Translation and validation of the Portuguese version of the Keratoconus Outcomes Research Questionnaire (KORQ). Arq Bras Olfalmol. 2021;84:430-5. doi:10.5935/0004-2749.20210067.
Kanellopoulos AJ, Asimellis G. Keratoconus management: long-term stability of topography-guided normalization combined with high-fluence CXL stabilization (the Athens Protocol). J Refract Surg. 2014;30:88-92. doi:10.3928/108159 7X-20140120-03.
Kandel H, Pesudovs K, Nguyen V, Chen J, Poon A, Mills R, et al. Patient-Reported Outcomes in Keratoconus: A Save Sight Keratoconus Registry Study. Cornea. 2023;42:590-7. doi:10.1097/ICO.000000000003119.
Kandel H, Nguyen V, Piermarocchi S, Ceklic L, Teo K, Arnalich-Montiel F, et al. Quality of life impact of eye diseases: a Save Sight Registries study. Clin Exp Ophthalmol. 2022;50:386-97. doi:10.1111/CEO.14050.
Sahebjada S, Fenwick E, Xie J, Snibson G, Daniell M, Baird P. Impact of Keratoconus in the Better Eye and the Worse Eye on Vision-Related Quality of Life. Invest Ophthalmol Vis Sci. 2014;55:412-6. doi:10.1167/IOVS.13-12929.
Tasgr Y, Taslipmar G, Eyidogan D, Sarac Ö, Çağıl N. Five-Year Long-Term Results of Standard Collagen Cross-Linking Therapy in Patients with Keratoconus. Turk J Ophthalmol. 2020;50:200. doi:10.4274/TJO.GALENOS.2020.53810.
Cingu A, Bez Y, Cinar Y, Turkcu F, Yildirim A, Sahin A, et al. Impact of Collagen Cross-linking on Psychological Distress and Vision and Health-Related Quality of Life in Patients With Keratoconus. Eye Contact Lens. 2015;41:349-53. doi:10.1097/ICL.0000000000000129.
Seiler TG, Fischinger I, Koller T, Zapp D, Frueh BE, Seiler T. Customized Corneal Cross-linking: One-Year Results. Am J Ophthalmol. 2016;166:14-21. doi:10.1016/j.ajo.2016.02.029.
Brooks N, Greenstein S, Fry K, Hersh P. Patient subjective visual function after corneal collagen crosslinking for keratoconus and corneal ectasia. J Cataract Refract Surg. 2012;38:615-9. doi:10.1016/J.JCRS.2011.11.029.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Sociedade Portuguesa de Oftalmologia

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here